ARNA Genomics
PrivateLast Round
Series A
Sep 17, 2020
Total Funding Raised
$5M
Company Overview
ARNA Genomics is a biotechnology company that develops liquid biopsy technologies for early cancer detection through the analysis of cell-free DNA in blood plasma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARNA Genomics Comparables
Compare ARNA Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuamark Diagnostics | 90% | |
| Adela | 86% | |
| 4D Lifetec | 84% | |
ARNA Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 17, 2020 | ||||
| Token Sale | Feb 11, 2018 |
Key People
Founding team and executive leadership
ARNA Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xploration Capital | Series A |
| Iskra Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2020
$4M round led by Xploration Capital.
- Feb 11, 2018
$450K raised in Token Sale round.
ARNA Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARNA Genomics's valuation, stock price, and market status.